# EH301 for the Treatment of ALS

> **NCT03489200** · NA · COMPLETED · sponsor: **Elysium Health** · enrollment: 32 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **OTHER:** EH301
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03489200
- **Lead sponsor:** Elysium Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03489200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03489200, "EH301 for the Treatment of ALS". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03489200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*